I look at this safety data as a huge plus, the fact that

I look at this safety data as a huge plus, the fact that we’re studying moderate to severe patients and there are patients alive to say that Brilacidin is safe is a great sign. Also the trial is still running and we are adding multiple sites a week. Can’t wait for top line data. Go IPIX. FYI still waiting on the FDA SRO list to come out.